Health Care & Life Sciences » Biotechnology | Genmab A/S

Genmab A/S

Genmab A/S ADR
Stock Exchange Other OTC
EPS
 $0.34
Market Cap
 $11.11 B
Shares Outstanding
 616.9 M
Public Float
 -
Genmab A/S
Stock Exchange Copenhagen Stock Exchange
EPS
 DKK21.71
Market Cap
 DKK73.86 B
Shares Outstanding
 61.69 M
Public Float
 60.44 M
Genmab A/S
Stock Exchange Frankfurt Stock Exchange
EPS
 EUR2.91
Market Cap
 EUR9.91 B
Shares Outstanding
 61.47 M
Public Float
 -
Genmab A/S
Stock Exchange London Stock Exchange
EPS
 -
Market Cap
 -
Shares Outstanding
 61.47 M
Public Float
 -

Profile

Address
Kalvebod Brygge 43
Copenhagen CR 1560
Denmark
Employees -
Website http://www.genmab.com
Updated 07/08/2019
Genmab A/S operates as an international biotechnology company. The firm develops human antibody therapeutics for the treatment of cancer. Its antibody product, Arzerra used in the treatment of chronic lymphocytic leukemia indications; and DARZALEX.

Financials

View All

Daniel John Bruno
Non-Independent Director & VP-Controller
Richard Gordon Hibbert
Non-Independent Director
View All

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.